Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 15/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.60 |
| ▸ | TMIGD3 | P0DMS9 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7680777 | 0.82 | ADORA3 (1.00) | ADORA3TRPV1TMIGD3ALDH1A1CACNA1D | |
| SCHEMBL7687629 | 0.81 | ADORA3 (0.75) | ADORA3TRPV1TMIGD3ALDH1A1CACNA1D | |
| SCHEMBL1664685 | 0.78 | ADORA3 (0.71) | ADORA3TRPV1TMIGD3ALDH1A1CACNA1D | |
| SCHEMBL7685108 | 0.77 | ADORA3 (0.74) | ADORA3TRPV1TMIGD3ALDH1A1CACNA1D | |
| SCHEMBL7685244 | 0.76 | ADORA3 (0.67) | ADORA3TRPV1TMIGD3ALDH1A1CACNA1D | |
| SCHEMBL7689462 | 0.75 | ADORA3 (1.00) | ADORA3TRPV1TMIGD3ALDH1A1CACNA1D | |
| SCHEMBL6962273 | 0.74 | ADORA3 (0.58) | ADORA3TRPV1TMIGD3ALDH1A1CACNA1D | |
| SCHEMBL11232571 | 0.73 | ADORA3 (0.57) | ADORA3ALDH1A1CACNA1D | |
| SCHEMBL13932305 | 0.73 | ADORA3 (1.00) | ADORA3TRPV1TMIGD3ALDH1A1 | |
| SCHEMBL8327248 | 0.72 | ADORA3 (0.68) | ADORA3TRPV1TMIGD3ALDH1A1CACNA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6376521-B1 | ANTIINFLAMMATORY AGENTS; ANTIISCHEMIC AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2002-04-23 | — | — | US | claimed |
| US-6376521-B1 | ANTIINFLAMMATORY AGENTS; ANTIISCHEMIC AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2002-04-23 | — | — | US | disclosed |